Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment.
about
Detection of Apolipoprotein E Gene Polymorphism and Blood Lipid Level in Hemodialysis Patients.Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs.How can the cardiac death rate be reduced in dialysis patients?Oxidative stress and its association with cardiovascular disease in chronic renal failure patientsEndothelial dysfunction in uremic patients on continuous ambulatory peritoneal dialysis (CAPD).Circulatory syndrome: an evolution of the metabolic syndrome concept!Association of coronary artery disease and chronic kidney disease in Lebanese populationPotential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients.Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients.Bioimpedance and echocardiography used interchangeably in volume comparison of dialysis patients.Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.Reno-cerebrovascular disease: linking the nephron and neuron.What are the causes of the ill effects of chronic hemodialysis? Balancing risks: blood pressure targets, intradialytic hypotension, and ischemic brain injury.Impact of Chronic Kidney Disease on Clinical Outcomes of Endovascular Treatment for Femoropopliteal Arterial Disease.Effect of On-Line Hemodiafiltration on P-Wave Dispersion in Children.Hemodiafiltration With Endogenous Reinfusion Improved Microinflammation and Endothelial Damage Compared With Online-Hemodiafiltration: A Hypothesis Generating Study.The influence of risk factors in remodelling carotid arteries in patients undergoing peritoneal dialysis.Arterial hypertension management with conversion enzyme inhibitors in hemodialysis patientsA comparative study of the effect of icodextrin based peritoneal dialysis and hemodialysis on lipid metabolismAtherosclerosis in patients with end-stage renal failure prior to initiation of hemodialysis.Mean arterial pressure and pulse pressure are associated with different clinical parameters in chronic haemodialysis patients.Randomized, placebo-controlled trial of intramuscular vitamin B12 for the treatment of hyperhomocysteinaemia in dialysis patients.Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients.Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients.Effects of extracellular acid stimulation on rat vascular smooth muscle cell in Gas6/Axl or PI3K/Akt signaling pathway.Serum alpha1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients.Effect of haemodialysis on regional and transmural inhomogeneities of the ventricular repolarisation phase.
P2860
Q33893953-69B876E2-3ECE-43CD-9185-0800701DA208Q34453236-527D2FD0-78FD-4246-A799-AFFD6C89CAA2Q34549918-A4FE2BD8-9505-4657-BDFE-F0AB06AD5F11Q35030157-6251D6A3-15D6-43E5-8921-97D0DF1C7EAEQ35184652-B22ADEDD-4CED-4B2B-B58A-3B247F17A6FCQ36087928-F470E7E4-9CA9-4D43-B74F-5ACFC9CDC8EEQ36317731-4CA1B679-1B33-4989-BD6B-553FBD5FBADEQ36892439-58D5194C-5511-4250-8AE9-BA0465741E2BQ36938839-C912ADB5-1B1C-4C49-819A-9F2AF164BAD4Q37083008-20745B11-CF76-4B56-BEB7-1EB268029DCAQ37298621-DDA514C0-CC35-4DC1-B1F0-FAD6B0F39180Q37838428-C43FAF18-A5B1-43FB-8E39-0DD42BE65835Q38153072-EC37A397-A7CA-4693-9B3C-C00D4DB1B898Q38870397-A34F62B7-AB76-43B8-8B37-5B9CC30B2969Q39433889-167FF9CF-DD5F-46D7-9154-B7DB3F76C794Q39763832-BFB4FE6B-E4D2-4C71-A7E6-28EF1FF76078Q41763608-630719EB-D674-48A1-AD82-65B994E46AE7Q41923359-BCB13863-83DF-4BD0-A729-E631BAB373C4Q42587543-1B3CF1EF-5F81-4087-A016-D7EAF6CCE6CBQ44435941-C7D2D5D0-518E-4B16-9F27-27FB15481C32Q44447287-2B259A4C-702B-45E5-8510-AC6F88545A1EQ44680327-C78D2B49-C84E-4688-81A2-EBC3D7CC9B46Q47930065-9729B506-2563-474E-865D-51294AAC689EQ50061267-F415ED92-A5AA-4CAF-A039-D7272735B9ACQ51672088-D2920797-F6F3-413F-907E-EFD64C50C8EAQ52011092-0CE8B06F-2D7C-44E6-9A29-8F9F1D0B1553Q52971656-2CD6858B-E68F-4A15-B197-4B350D8D2A5A
P2860
Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cardiovascular disease determi ...... inical approach and treatment.
@ast
Cardiovascular disease determi ...... inical approach and treatment.
@en
Cardiovascular disease determi ...... inical approach and treatment.
@nl
type
label
Cardiovascular disease determi ...... inical approach and treatment.
@ast
Cardiovascular disease determi ...... inical approach and treatment.
@en
Cardiovascular disease determi ...... inical approach and treatment.
@nl
prefLabel
Cardiovascular disease determi ...... inical approach and treatment.
@ast
Cardiovascular disease determi ...... inical approach and treatment.
@en
Cardiovascular disease determi ...... inical approach and treatment.
@nl
P2093
P356
P1476
Cardiovascular disease determi ...... inical approach and treatment.
@en
P2093
Locatelli F
Martín-Malo A
P304
P356
10.1093/NDT/16.3.459
P407
P577
2001-03-01T00:00:00Z